Geneva scientists find way to slow development of lymphoma
Scientists in Geneva have found a way to slow down the development of lymphoma, the cancer that affects white blood cells.
The research by the University of Geneva (UNIGE) and the University Hospitals of Geneva (HUG) is still in the experimental stage, but it could eventually lead to new treatments against the disease.
Researchers used an antibody capable of blocking cancer cell migration. They are then trapped in blood vessels, where they can't survive for long.
This means they can no longer seep into nodes, spleen or bone marrow and form tumors.
The discovery in Geneva is in line with recent work in the field of cancer immunotherapy, to design treatments based on the human immune system.
The aim is to be able to offer a treatment to patients in the next few years.